Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle -- Ignore unavailable to you. Want to Upgrade?

To: ArtAlley who wrote (4912)	1/18/1999 7:13:00 AM
From: ArtAlley	Read Replies (1) \| Respond to of 56535

ASCT question: isn't their cash on position very low? Could this make it tough to stay in business if the take over does NOT occur?

To: ArtAlley who wrote (4912)	1/18/1999 12:00:00 PM
From: Trader J	Read Replies (1) \| Respond to of 56535

ArtAlley: ASCT - Yes those drugs Primsol and the other one (I forgot the name) are what everyone is banking on. If they do get bought out, it will be long before these drugs are approved as after the fact, ASCT would most likely ask for a higher price. This is the reason that I will hold at least a couple thousand shares going forward, buyout or no buyout. I will just mentally move it to my longer portfolio at the end of Jan if we hear nothing before then. I have heard enough thus far to warrant holding as eventually it will go IMO. But we are traders, for the most part here, waiting for 10 points over a few months may not be worth it for some, when you can use the money for the next IMON play or the like. The decision will be up to each ASCT holder. At the end of Jan, if I still have heard nothing, I will sell half and move on. Trade well. TJ